Omeros CorpNASDAQ:OMER
- LAST PRICE10.9100
- TODAY'S CHANGE (%)3.1800 (41.1384%)
- Bid / Lots10.7600/ 2
- Ask / Lots11.0000/ 3
- Open / Previous Close7.7000 / 7.7300
- Day Range
- 52 Week Range
- Volume4,068,706
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMER |
|---|---|---|
| 09:32 ET | 47260 | 7.775 |
| 09:33 ET | 23148 | 7.4889 |
| 09:35 ET | 8772 | 7.6 |
| 09:37 ET | 3982 | 7.77 |
| 09:39 ET | 1793 | 7.7922 |
| 09:42 ET | 5937 | 7.9 |
| 09:44 ET | 29155 | 8.18 |
| 09:46 ET | 22591 | 8.21 |
| 09:48 ET | 22845 | 8.28 |
| 09:50 ET | 81825 | 8.6884 |
| 09:51 ET | 24052 | 8.76 |
| 09:53 ET | 38954 | 8.69 |
| 09:55 ET | 13566 | 8.81 |
| 09:57 ET | 9583 | 8.865 |
| 10:00 ET | 26875 | 8.98 |
| 10:02 ET | 12489 | 8.93 |
| 10:04 ET | 29607 | 8.87 |
| 10:06 ET | 6219 | 8.8 |
| 10:08 ET | 14931 | 8.775 |
| 10:09 ET | 80502 | 9.175 |
| 10:11 ET | 13836 | 9.0298 |
| 10:13 ET | 8105 | 9.07 |
| 10:15 ET | 35782 | 9.28 |
| 10:18 ET | 27719 | 9.365 |
| 10:20 ET | 31144 | 9.34 |
| 10:22 ET | 39221 | 9.3994 |
| 10:24 ET | 39125 | 9.4505 |
| 10:26 ET | 34837 | 9.69 |
| 10:27 ET | 19499 | 9.7 |
| 10:29 ET | 56169 | 9.3988 |
| 10:31 ET | 32567 | 9.435 |
| 10:33 ET | 48096 | 9.13 |
| 10:36 ET | 16215 | 9.095 |
| 10:38 ET | 10507 | 9.1475 |
| 10:40 ET | 24538 | 9.13 |
| 10:42 ET | 29839 | 9.005 |
| 10:44 ET | 22853 | 8.9448 |
| 10:45 ET | 9814 | 9.025 |
| 10:47 ET | 14816 | 9.07 |
| 10:49 ET | 12896 | 9.2037 |
| 10:51 ET | 6723 | 9.32 |
| 10:54 ET | 12372 | 9.35 |
| 10:56 ET | 29804 | 9.38 |
| 10:58 ET | 15207 | 9.45 |
| 11:00 ET | 16467 | 9.44 |
| 11:02 ET | 8466 | 9.442 |
| 11:03 ET | 15416 | 9.49 |
| 11:05 ET | 35137 | 9.605 |
| 11:07 ET | 24129 | 9.53 |
| 11:09 ET | 8885 | 9.56 |
| 11:12 ET | 8853 | 9.535 |
| 11:14 ET | 18338 | 9.5187 |
| 11:16 ET | 16141 | 9.565 |
| 11:18 ET | 8296 | 9.52 |
| 11:20 ET | 4265 | 9.465 |
| 11:21 ET | 2550 | 9.48 |
| 11:23 ET | 3368 | 9.49 |
| 11:25 ET | 2214 | 9.485 |
| 11:27 ET | 26169 | 9.65 |
| 11:30 ET | 44736 | 9.58 |
| 11:32 ET | 6948 | 9.5223 |
| 11:34 ET | 8918 | 9.46 |
| 11:36 ET | 1971 | 9.42 |
| 11:38 ET | 6717 | 9.52 |
| 11:39 ET | 2458 | 9.46 |
| 11:41 ET | 305 | 9.46 |
| 11:43 ET | 4845 | 9.405 |
| 11:45 ET | 23849 | 9.5 |
| 11:48 ET | 11731 | 9.54 |
| 11:50 ET | 2427 | 9.59 |
| 11:52 ET | 13367 | 9.7157 |
| 11:54 ET | 16160 | 9.57 |
| 11:56 ET | 21484 | 9.5804 |
| 11:57 ET | 18593 | 9.5699 |
| 11:59 ET | 18300 | 9.41 |
| 12:01 ET | 13105 | 9.51 |
| 12:03 ET | 6018 | 9.4851 |
| 12:06 ET | 4929 | 9.55 |
| 12:08 ET | 7412 | 9.555 |
| 12:10 ET | 1721 | 9.57 |
| 12:12 ET | 2014 | 9.52 |
| 12:14 ET | 5657 | 9.56 |
| 12:15 ET | 3221 | 9.52 |
| 12:17 ET | 11209 | 9.56 |
| 12:19 ET | 1310 | 9.5699 |
| 12:21 ET | 18543 | 9.48 |
| 12:24 ET | 2800 | 9.4402 |
| 12:26 ET | 1200 | 9.46 |
| 12:28 ET | 200 | 9.4663 |
| 12:30 ET | 2470 | 9.45 |
| 12:32 ET | 3912 | 9.45 |
| 12:33 ET | 2987 | 9.47 |
| 12:35 ET | 8960 | 9.48 |
| 12:37 ET | 7637 | 9.48 |
| 12:39 ET | 9217 | 9.47 |
| 12:42 ET | 1629 | 9.49 |
| 12:44 ET | 350 | 9.4816 |
| 12:46 ET | 3795 | 9.465 |
| 12:48 ET | 7599 | 9.5 |
| 12:50 ET | 7779 | 9.5009 |
| 12:51 ET | 11044 | 9.51 |
| 12:53 ET | 9132 | 9.49 |
| 12:55 ET | 9073 | 9.43 |
| 12:57 ET | 2325 | 9.46 |
| 01:00 ET | 5032 | 9.425 |
| 01:02 ET | 1900 | 9.43 |
| 01:04 ET | 977 | 9.43 |
| 01:06 ET | 3609 | 9.425 |
| 01:08 ET | 4731 | 9.47 |
| 01:09 ET | 300 | 9.4676 |
| 01:11 ET | 7912 | 9.53 |
| 01:13 ET | 10249 | 9.55 |
| 01:15 ET | 3684 | 9.5871 |
| 01:18 ET | 8813 | 9.585 |
| 01:20 ET | 6455 | 9.5999 |
| 01:22 ET | 244 | 9.58 |
| 01:24 ET | 31708 | 9.72 |
| 01:26 ET | 3880 | 9.68 |
| 01:27 ET | 2580 | 9.65 |
| 01:29 ET | 900 | 9.66 |
| 01:31 ET | 4104 | 9.64 |
| 01:33 ET | 7289 | 9.645 |
| 01:36 ET | 2428 | 9.58 |
| 01:38 ET | 16145 | 9.65 |
| 01:40 ET | 5897 | 9.605 |
| 01:42 ET | 500 | 9.59 |
| 01:44 ET | 1000 | 9.59 |
| 01:45 ET | 2855 | 9.58 |
| 01:47 ET | 17492 | 9.65 |
| 01:49 ET | 19419 | 9.815 |
| 01:51 ET | 12089 | 9.835 |
| 01:54 ET | 20566 | 9.86 |
| 01:56 ET | 6757 | 9.886 |
| 01:58 ET | 44433 | 9.97 |
| 02:00 ET | 26881 | 9.95 |
| 02:02 ET | 25114 | 9.98 |
| 02:03 ET | 4831 | 9.96 |
| 02:05 ET | 34230 | 9.9893 |
| 02:07 ET | 95028 | 9.98 |
| 02:09 ET | 20173 | 10.015 |
| 02:12 ET | 27671 | 9.982 |
| 02:14 ET | 18703 | 10.0037 |
| 02:16 ET | 25266 | 10.105 |
| 02:18 ET | 3060 | 10.074 |
| 02:20 ET | 7817 | 10.1261 |
| 02:21 ET | 7324 | 10.155 |
| 02:23 ET | 27569 | 10.2 |
| 02:25 ET | 23260 | 10.32 |
| 02:27 ET | 17498 | 10.3679 |
| 02:30 ET | 7942 | 10.4016 |
| 02:32 ET | 16929 | 10.48 |
| 02:34 ET | 13045 | 10.37 |
| 02:36 ET | 9094 | 10.362 |
| 02:38 ET | 8260 | 10.29 |
| 02:39 ET | 12771 | 10.3093 |
| 02:41 ET | 2044 | 10.34 |
| 02:43 ET | 14740 | 10.27 |
| 02:45 ET | 4947 | 10.19 |
| 02:48 ET | 8220 | 10.13 |
| 02:50 ET | 10769 | 10.21 |
| 02:52 ET | 5254 | 10.21 |
| 02:54 ET | 1960 | 10.2 |
| 02:56 ET | 7678 | 10.23 |
| 02:57 ET | 8749 | 10.24 |
| 02:59 ET | 31216 | 10.38 |
| 03:01 ET | 9117 | 10.4262 |
| 03:03 ET | 5648 | 10.415 |
| 03:06 ET | 10958 | 10.36 |
| 03:08 ET | 3060 | 10.3801 |
| 03:10 ET | 49075 | 10.44 |
| 03:12 ET | 7943 | 10.35 |
| 03:14 ET | 1584 | 10.31 |
| 03:15 ET | 5969 | 10.345 |
| 03:17 ET | 19694 | 10.339 |
| 03:19 ET | 18858 | 10.435 |
| 03:21 ET | 68422 | 10.58 |
| 03:24 ET | 8875 | 10.6 |
| 03:26 ET | 16389 | 10.44 |
| 03:28 ET | 12067 | 10.5399 |
| 03:30 ET | 29661 | 10.49 |
| 03:32 ET | 16338 | 10.5 |
| 03:33 ET | 96614 | 10.5148 |
| 03:35 ET | 18813 | 10.6199 |
| 03:37 ET | 24472 | 10.695 |
| 03:39 ET | 44030 | 10.71 |
| 03:42 ET | 21534 | 10.7788 |
| 03:44 ET | 20995 | 10.825 |
| 03:46 ET | 13625 | 10.8 |
| 03:48 ET | 47079 | 10.82 |
| 03:50 ET | 39369 | 10.765 |
| 03:51 ET | 49593 | 10.96 |
| 03:53 ET | 45612 | 10.91 |
| 03:55 ET | 38449 | 10.775 |
| 03:57 ET | 51996 | 10.84 |
| 04:00 ET | 332805 | 10.91 |
Nov 21, 2024
Omeros Corporation Provides Update on Progress Toward BLA Resubmission, from 9:15AM ET on Thursday Nov 21, 2024 by Dow Jones
9:15AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 14, 2024
DJ Omeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab Application, from 1:33PM ET on Thursday Nov 14, 2024 by Dow Jones
1:33PM ET on Thursday Nov 14, 2024 by Dow JonesDJ Omeros Up Over 49%, On Pace for Largest Percent Increase Since February 2023 -- Data Talk, from 11:25AM ET on Thursday Nov 14, 2024 by Dow Jones
11:25AM ET on Thursday Nov 14, 2024 by Dow JonesDJ Omeros Initiated at Buy by Rodman & Renshaw, from 7:04AM ET on Thursday Nov 14, 2024 by Dow Jones
7:04AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Omeros Corporation Reports Third Quarter 2024 Financial Results, from 4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omeros Corp | 632.2M | -3.5x | --- |
Mineralys Therapeutics Inc | 621.1M | -3.8x | --- |
MBX Biosciences Inc | 618.2M | 0.0x | --- |
Altimmune Inc | 616.9M | -5.6x | --- |
SS Innovations International Inc | 631.7M | -22.6x | --- |
Tourmaline Bio Inc | 590.0M | -13.7x | --- |
Company Information
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in a phase I multi-ascending-dose clinical trial. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria and complement 3 glomerulopathy. The Company’s lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorders.
Contact Information
- Headquarters
- 201 Elliott Avenue WestSEATTLE, WA, United States 98119
- Phone
- 206-676-5000
- Fax
- 206-676-5005
Executives
- Chairman of the Board, President, Chief Executive Officer
- Gregory Demopulos
- Chief Accounting Officer, Vice President - Finance, Treasurer
- David Borges
- Vice President - Science, Chief Scientific Officer
- George Gaitanaris
- Vice President, General Counsel, Secretary
- Peter Cancelmo
- Vice President - Human Resources
- Peter Williams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $632.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.84 |
EPS | $-3.14 |
Book Value | $-0.41 |
P/E Ratio | -3.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
